导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.98% | 1771/4773 |
| 近一周 | 0.27% | 112/5462 |
| 近一月 | 1.85% | 304/5421 |
| 近一季 | 0.95% | 602/5209 |
| 近半年 | -2.09% | 1776/4920 |
| 近一年 | 3.60% | 1900/4366 |
| 近两年 | 28.03% | 2362/2954 |
| 近三年 | 29.91% | 1058/2253 |
| 成立以来 | 103.33% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.49% 913/4961 |
-8.69% 3910/5312 |
- - |
- - |
| 2025 | 2.72% 3167/4813 |
-1.70% 2752/3635 |
3.31% 1057/4076 |
-1.87% 3969/4524 |
3.08% 757/4813 |
| 2024 | 31.02% 103/3463 |
10.82% 37/2808 |
3.80% 248/3014 |
11.59% 2497/3129 |
2.07% 987/3463 |
| 2023 | 15.92% 32/2656 |
11.74% 325/2280 |
6.35% 43/2385 |
2.77% 219/2515 |
-5.08% 1249/2655 |
| 2022 | -3.80% 72/2207 |
-1.37% 145/1919 |
-1.26% 1694/2016 |
-4.84% 66/2113 |
3.81% 638/2208 |
| 2021 | 19.30% 196/1822 |
11.33% 26/1255 |
-0.57% 1142/1330 |
8.41% 158/1466 |
-0.59% 1252/1822 |
| 2020 | - - |
- - |
-0.59% 1021/1067 |
10.90% 499/1164 |
5.31% 792/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 南方红利低波50ETF VS. 长安沪深300非周期A(740101) |